Ablation of the ATP-binding cassette transporter, Abca2 modifies response to estrogen-based therapies.

Author: BrownCarol B, GarrettTracy E, MackJody T, TewKenneth D, TownsendDanyelle M, UysJoachim D

Paper Details 
Original Abstract of the Article :
The ATP-binding cassette transporter 2 (ABCA2) is an endolysosomal protein expressed in oligodendrocytes and Schwann cells, prostate, ovary and macrophages. In cell cultures, ABCA2 over-expression has been linked with resistance to the anticancer agent, estramustine phosphate (EMP; a nor-nitrogen mu...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/22898081

データ提供:米国国立医学図書館(NLM)

The Role of ABCA2 in Estrogen-Based Therapies: A Journey Through the Desert of Drug Response

This study delves into the complex world of drug response, focusing on the role of the ATP-binding cassette transporter 2 (ABCA2) in modifying the effectiveness of estrogen-based therapies. The researchers investigated the impact of ABCA2 deficiency in mice on their sensitivity to the anticancer drug estramustine phosphate (EMP). Their findings highlight the crucial role of ABCA2 in regulating EMP transport and/or metabolism, suggesting that its presence or absence can significantly influence the effectiveness and side effects of this drug.

ABCA2: A Gatekeeper in the Desert of Drug Response

The study reveals that mice lacking ABCA2 exhibited increased sensitivity to the side effects of EMP treatment, experiencing higher mortality rates and more pronounced adverse effects. The study also suggests that ABCA2 may play a role in regulating the erectile process, potentially influencing the effectiveness of EMP in treating prostate cancer. These findings underscore the importance of understanding the complex interplay between drug transporters and individual variability in drug response.

Navigating the Desert of Personalized Medicine: Understanding Drug Transport

This research is like a compass guiding us through the vast and often unpredictable desert of drug response. It highlights the importance of understanding the role of drug transporters, like ABCA2, in determining individual sensitivity to medications. This research emphasizes the need for personalized approaches to drug therapy, considering individual genetic and physiological differences to optimize treatment outcomes and minimize side effects.

Dr. Camel's Conclusion

This study reminds us that the desert of drug response is a vast and complex landscape. Understanding the role of drug transporters, like ABCA2, is crucial for navigating this terrain and ensuring safe and effective drug therapies. It underscores the importance of personalized approaches to medicine, tailoring treatments to individual needs and maximizing the benefits while minimizing the risks.

Date :
  1. Date Completed 2013-01-30
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

22898081

DOI: Digital Object Identifier

NIHMS486646

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.